Mar 20, 2023 7:00am EDT Societal CDMO Announces U.S. FDA Approval for Manufacturing of Commercial Tablet at Gainesville, Georgia Site
Feb 22, 2023 4:05pm EST Societal CDMO to Report Financial Results for Fourth Quarter and Year-End 2022 on March 1, 2023
Feb 01, 2023 7:00am EST Societal CDMO Highlights Growth of Existing Customer Business Through Signing of More Than $6 Million in Work Orders During Fourth Quarter of 2022
Dec 16, 2022 9:25am EST Societal CDMO Completes Strategic Recast of Capital Structure Highlighted by Reduction and Refinancing of Outstanding Debt
Dec 12, 2022 6:45am EST Societal CDMO Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock